Myosin II isoforms play distinct roles in adherens junction biogenesis

  1. Mélina L Heuze  Is a corresponding author
  2. Gautham Sankara
  3. Joseph D'Alessandro
  4. Victor Cellerin
  5. Tien Dang
  6. David S Williams
  7. Jan CM Van Hest
  8. Philippe Marcq
  9. René-Marc Mège  Is a corresponding author
  10. Benoit Ladoux  Is a corresponding author
  1. CNRS, France
  2. Swansea University, United Kingdom
  3. Eindhoven University of Technology, Netherlands
  4. Sorbonne Université, France

Abstract

Adherens junction (AJ) assembly under force is essential for many biological processes like epithelial monolayer bending, collective cell migration, cell extrusion and wound healing. The acto-myosin cytoskeleton acts as a major force-generator during the de novo formation and remodelling of AJ. Here, we investigated the role of myosinII isoforms in epithelial junction assembly. Myosin IIA (NMIIA) and Myosin IIB (NMIIB) differentially regulate biogenesis of adherens junction through association with distinct actin networks. Analysis of junction dynamics, actin organization, and mechanical forces of control and knockdown cells for myosins revealed that NMIIA provides the mechanical tugging force necessary for cell-cell junction reinforcement and maintenance. NMIIB is involved in E-cadherin clustering, maintenance of a branched actin layer connecting E-cadherin complexes and perijunctional actin fibres leading to the building-up of anisotropic stress. These data reveal unanticipated complementary functions of NMIIA and NMIIB in the biogenesis and integrity of AJ.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for the main figures and figure supplements.

Article and author information

Author details

  1. Mélina L Heuze

    Institut Jacques Monod, CNRS, Paris, France
    For correspondence
    melina.heuze@ijm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4271-2706
  2. Gautham Sankara

    Institut Jacques Monod, CNRS, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Joseph D'Alessandro

    Institut Jacques Monod, CNRS, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1585-3255
  4. Victor Cellerin

    Institut Jacques Monod, CNRS, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Tien Dang

    Institut Jacques Monod, CNRS, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. David S Williams

    Department of Chemistry, Swansea University, Swansea, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Jan CM Van Hest

    Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  8. Philippe Marcq

    Laboratoire Physique et Mécanique des Milieux Hétérogènes, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. René-Marc Mège

    Institut Jacques Monod, CNRS, Paris, France
    For correspondence
    rene-marc.mege@ijm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8128-5543
  10. Benoit Ladoux

    Institut Jacques Monod, CNRS, Paris, France
    For correspondence
    benoit.ladoux@ijm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2086-1556

Funding

Seventh Framework Programme (CoG-617233)

  • Benoit Ladoux

Agence Nationale de la Recherche (ANR-17-CE13-0013)

  • René-Marc Mège

Agence Nationale de la Recherche (ANR-10-INBS-04)

  • René-Marc Mège
  • Benoit Ladoux

Agence Nationale de la Recherche (ANR‐11‐LABX‐0071)

  • René-Marc Mège
  • Benoit Ladoux

Agence Nationale de la Recherche (ANR-11-LABX-0071)

  • Benoit Ladoux

Agence Nationale de la Recherche (ANR-17-CE13-0012)

  • Benoit Ladoux

Ligue Contre le Cancer (Equipe Labellisée)

  • René-Marc Mège

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Heuze et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,020
    views
  • 635
    downloads
  • 71
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mélina L Heuze
  2. Gautham Sankara
  3. Joseph D'Alessandro
  4. Victor Cellerin
  5. Tien Dang
  6. David S Williams
  7. Jan CM Van Hest
  8. Philippe Marcq
  9. René-Marc Mège
  10. Benoit Ladoux
(2019)
Myosin II isoforms play distinct roles in adherens junction biogenesis
eLife 8:e46599.
https://doi.org/10.7554/eLife.46599

Share this article

https://doi.org/10.7554/eLife.46599

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.